Cargando…
Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a characteristic dysregulated metabolism. Abnormal clinicopathological features linked to defective metabolic and inflammatory response pathways can induce PDAC development and progression. In this study, we investigated the metabolites...
Autores principales: | Elebo, Nnenna, Omoshoro-Jones, Jones, Fru, Pascaline N., Devar, John, De Wet van Zyl, Christiaan, Vorster, Barend Christiaan, Smith, Martin, Cacciatore, Stefano, Zerbini, Luiz F., Candy, Geoffrey, Nweke, Ekene Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540259/ https://www.ncbi.nlm.nih.gov/pubmed/34677378 http://dx.doi.org/10.3390/metabo11100663 |
Ejemplares similares
-
Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer
por: Elebo, Nnenna, et al.
Publicado: (2020) -
SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways
por: Nweke, Ekene Emmanuel, et al.
Publicado: (2020) -
Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
por: Xelwa, Ntombikayise, et al.
Publicado: (2021) -
Chemokine receptor 8 expression may be linked to disease severity and elevated interleukin 6 secretion in acute pancreatitis
por: Nalisa, Mwangala, et al.
Publicado: (2021) -
Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
por: Elebo, Nnenna, et al.
Publicado: (2023)